U.S. Prescription Drug Prices See Significant Decline, White House Attributes to 'Most Favored Nation' Policies

The White House announced the largest annual drop in U.S. prescription drug prices in over six decades, marking the steepest decline since 1963. This reduction is attributed to the Trump Administration's "Most Favored Nation" policies, which aim to align domestic drug costs with those in other developed countries. This development could significantly impact healthcare affordability for many Americans.